New Endeavors by Women

Audits
3
Findings
64
Total Expended
$3.05M
Latest Accepted
2025-03-31
Location: Washington, DC
UEI: PFK6H8F57MS1 EIN: 521547845

SAM.gov Exclusion Status:

Checking exclusion status...

Audits by Year

  • 2022 1
  • 2023 1
  • 2024 1

Top Programs

By expenditures

Contacts

Name Title Type
Wanda Steptoe EXECUTIVE DIRECTOR Auditee
Lindsay Dean Director Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
351635 2024 2025-03-31 Gelman Rosenberg & Freedman $1.00M
309829 2023 2024-06-25 Gelman Rosenberg & Freedman $1.02M
34209 2022 2023-03-22 Gelman Rosenberg & Freedman $1.02M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
351635 2024 2025-03-31 1123841 2024-003 Significant Deficiency - I
351635 2024 2025-03-31 1123840 2024-002 Significant Deficiency Yes P
351635 2024 2025-03-31 1123839 2024-003 Significant Deficiency - I
351635 2024 2025-03-31 1123838 2024-002 Significant Deficiency Yes P
351635 2024 2025-03-31 1123837 2024-003 Significant Deficiency - I
351635 2024 2025-03-31 1123836 2024-002 Significant Deficiency Yes P
351635 2024 2025-03-31 1123835 2024-003 Significant Deficiency - I
351635 2024 2025-03-31 1123834 2024-002 Significant Deficiency Yes P
351635 2024 2025-03-31 547399 2024-003 Significant Deficiency - I
351635 2024 2025-03-31 547398 2024-002 Significant Deficiency Yes P
351635 2024 2025-03-31 547397 2024-003 Significant Deficiency - I
351635 2024 2025-03-31 547396 2024-002 Significant Deficiency Yes P
351635 2024 2025-03-31 547395 2024-003 Significant Deficiency - I
351635 2024 2025-03-31 547394 2024-002 Significant Deficiency Yes P
351635 2024 2025-03-31 547393 2024-003 Significant Deficiency - I
351635 2024 2025-03-31 547392 2024-002 Significant Deficiency Yes P
309829 2023 2024-06-25 978354 2023-003 Significant Deficiency Yes I
309829 2023 2024-06-25 978353 2023-002 Significant Deficiency Yes P
309829 2023 2024-06-25 978352 2023-001 Material Weakness Yes P
309829 2023 2024-06-25 978351 2023-003 Significant Deficiency Yes I
309829 2023 2024-06-25 978350 2023-002 Significant Deficiency Yes P
309829 2023 2024-06-25 978349 2023-001 Material Weakness Yes P
309829 2023 2024-06-25 978348 2023-003 Significant Deficiency Yes I
309829 2023 2024-06-25 978347 2023-002 Significant Deficiency Yes P
309829 2023 2024-06-25 978346 2023-001 Material Weakness Yes P
309829 2023 2024-06-25 978345 2023-003 Significant Deficiency Yes I
309829 2023 2024-06-25 978344 2023-002 Significant Deficiency Yes P
309829 2023 2024-06-25 978343 2023-001 Material Weakness Yes P
309829 2023 2024-06-25 401912 2023-003 Significant Deficiency Yes I
309829 2023 2024-06-25 401911 2023-002 Significant Deficiency Yes P
309829 2023 2024-06-25 401910 2023-001 Material Weakness Yes P
309829 2023 2024-06-25 401909 2023-003 Significant Deficiency Yes I
309829 2023 2024-06-25 401908 2023-002 Significant Deficiency Yes P
309829 2023 2024-06-25 401907 2023-001 Material Weakness Yes P
309829 2023 2024-06-25 401906 2023-003 Significant Deficiency Yes I
309829 2023 2024-06-25 401905 2023-002 Significant Deficiency Yes P
309829 2023 2024-06-25 401904 2023-001 Material Weakness Yes P
309829 2023 2024-06-25 401903 2023-003 Significant Deficiency Yes I
309829 2023 2024-06-25 401902 2023-002 Significant Deficiency Yes P
309829 2023 2024-06-25 401901 2023-001 Material Weakness Yes P
34209 2022 2023-03-22 609099 2022-003 Significant Deficiency Yes I
34209 2022 2023-03-22 609098 2022-002 Significant Deficiency - P
34209 2022 2023-03-22 609097 2022-001 Significant Deficiency - P
34209 2022 2023-03-22 609096 2022-003 Significant Deficiency Yes I
34209 2022 2023-03-22 609095 2022-002 Significant Deficiency - P
34209 2022 2023-03-22 609094 2022-001 Significant Deficiency - P
34209 2022 2023-03-22 609093 2022-003 Significant Deficiency Yes I
34209 2022 2023-03-22 609092 2022-002 Significant Deficiency - P
34209 2022 2023-03-22 609091 2022-001 Significant Deficiency - P
34209 2022 2023-03-22 609090 2022-003 Significant Deficiency Yes I
34209 2022 2023-03-22 609089 2022-002 Significant Deficiency - P
34209 2022 2023-03-22 609088 2022-001 Significant Deficiency - P
34209 2022 2023-03-22 32657 2022-003 Significant Deficiency Yes I
34209 2022 2023-03-22 32656 2022-002 Significant Deficiency - P
34209 2022 2023-03-22 32655 2022-001 Significant Deficiency - P
34209 2022 2023-03-22 32654 2022-003 Significant Deficiency Yes I
34209 2022 2023-03-22 32653 2022-002 Significant Deficiency - P
34209 2022 2023-03-22 32652 2022-001 Significant Deficiency - P
34209 2022 2023-03-22 32651 2022-003 Significant Deficiency Yes I
34209 2022 2023-03-22 32650 2022-002 Significant Deficiency - P
34209 2022 2023-03-22 32649 2022-001 Significant Deficiency - P
34209 2022 2023-03-22 32648 2022-003 Significant Deficiency Yes I
34209 2022 2023-03-22 32647 2022-002 Significant Deficiency - P
34209 2022 2023-03-22 32646 2022-001 Significant Deficiency - P